Patent ID: 8906949

Claim:
An orally disintegrating tablet formulation of zolmitriptan or a pharmaceutically acceptable salt thereof consisting of: a) 1.0 to 10.0% by weight of zolmitriptan or a pharmaceutically acceptable salt thereof; b) 2.0 to 90.0% by weight of mannitol; c) 2.0 to 90.0% by weight of magnesium carbonate heavy; d) 0.5 to 30.0% by weight of crospovidone; e) 0.1 to 10.0% by weight of polyvinylpyrrolidone; f) 0.01 to 5.00% by weight of sucralose; g) 0.05 to 5.0% by weight of flavoring agent; and h) 0.1 to 10.0% by weight of sodium stearyl fumarate.